Bispecific dual-payload ADCs
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
200
NCT07181473
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 25, 2025
Completion: Sep 15, 2027
Loading map...